News & Updates
Search Research Content
Combined Therapy against Recurrent Hemangiopericytoma: A Case Report.
|Title||Combined Therapy against Recurrent Hemangiopericytoma: A Case Report.|
|Publication Type||Journal Article|
|Year of Publication||2012|
|Authors||Li X-D, Jiang J-T, Wu C-P|
|Journal||Cancer biology & medicine|
|Date Published||2012 Jun|
Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.
|Alternate Journal||Cancer Biol Med|